January 28, 2026 a 08:38 pm

MDT: Analysts Ratings - Medtronic plc

Medtronic plc stock assessment

Medtronic plc, a leader in medical technology, has seen varying analyst recommendations over recent months, reflecting market sentiment trends. The company shows a strong performance in the cardiovascular and medical surgical markets, which is mirrored in the overall positive analyst ratings, with a considerable number of 'Buy' and 'Hold' recommendations. Current trends suggest cautious optimism with a stable outlook, avoiding extreme ratings like 'Strong Sell'.

Historical Stock Grades

Recommendation Count Score
Strong Buy 4
Buy 13
Hold 15
Sell 0
Strong Sell 0
Analyst ratings history for MDT Stock chart of MDT

Sentiment Development

- In the last few months, a trend towards more conservative 'Hold' recommendations is evident, indicating cautious investor sentiment. - The number of 'Buy' recommendations has remained relatively stable, with no significant increase in 'Strong Buy' suggesting a steady yet positive outlook. - Over the months, the total number of ratings has slightly increased, reflecting more analyst activity and interest in the stock.

Percentage Trends

- There's a discernible shift in sentiment with fewer 'Strong Buy' ratings and increased 'Hold' recommendations, suggesting some uncertainty among analysts. - The proportion of 'Buy' ratings remains dominant but shows no further growth, signaling a stable yet careful approach. - Over the last year, the persistence of 'Hold' ratings indicates a wait-and-see approach among market participants. - Significant observations include the reduction in absolute 'Strong Buy' numbers from previous highs seen in early 2024, reflecting readjusted market expectations.

Latest Analyst Recommendations

Date New Recommendation Last Recommendation Publisher
2026-01-09 Outperform Outperform Bernstein
2026-01-08 Overweight Overweight Barclays
2026-01-06 Outperform Market Perform William Blair
2025-12-18 Hold Hold Truist Securities
2025-11-20 Hold Hold Truist Securities

Analyst Recommendations with Change of Opinion

Date New Recommendation Last Recommendation Publisher
2026-01-06 Outperform Market Perform William Blair
2025-11-19 Neutral Sell Goldman Sachs
2025-06-30 Peer Perform Underperform Wolfe Research
2025-03-04 Buy Neutral Citigroup
2024-10-10 Outperform Sector Perform RBC Capital

Interpretation

The current market sentiment towards Medtronic plc indicates a cautious optimism, with a substantial number of analysts maintaining 'Buy' and 'Hold' positions. The stability in analyst sentiment suggests resilience in the company's fundamentals, while the shifts towards more conservative recommendations reflect broader market caution or sector-specific concerns. Recent upgrades indicate a positive reassessment of potential growth opportunities. Overall, the sentiment reflects cautious confidence in Medtronic's ability to navigate market challenges.

Conclusion

Medtronic plc's stock ratings reveal a balanced sentiment with an underlying favorable outlook, highlighted by consistent 'Buy' and 'Hold' ratings. Although slight declines in 'Strong Buy' recommendations indicate moderated enthusiasm, the absence of negative ratings such as 'Sell' or 'Strong Sell' confirms trust in the company's market performance. The increase in 'Hold' ratings tempers anticipation, but analyst upgrades suggest renewed confidence in specific company initiatives. Investors should weigh these insights against market trends, considering Medtronic as a stable investment with potential upsides dictated by strategic positioning in growing healthcare segments.